Biodiversity and Bioprospecting
The Brazilian territory has one of the greatest life diversities on the planet, which makes the country the subject of considerable interest concerning the use of economic resources. After the development of biotechnology, it has been observed that the more biodiversity, the more pharmacological products could be developed.
According to Article 7 of the Convention on Biological Diversity, held in the Conference on Environment and Development – Rio-92, biodiversity is defined as the variability among living organisms from all sources, including many terrestrial, freshwater and marine ecosystems. It also includes all the ecological interactions that are part; diversity within species, between species and among ecosystems. Biodiversity encompasses all living resources of the earth's surface, and is essential for humanity can be considered as a set of riches, a natural heritage of a nation or a continent.
The pharmaceutical industry has been resuming the idea that the healing of thousands of human diseases may rely on the products extracted from the natural biological resources of the various rain forests and other ecosystems. The great demand for therapeutically relevant bioactive compounds extracted from natural resources boosted bioprospecting, which can be defined as a method that identifies, isolates, evaluates and explores systematically and legally the diversity of biomolecules in a particular organism or ecosystem. Its main goal is the search for genetic and biochemical resources with commercial purposes.
Evidences show that one third of the most prescribed and most sold medicines are derived from biodiversity, even antibiotics and drugs for cancer treatment – in this case, the number could reach 70%.
Phytoplenus is fully compliant with the policy of preserving the Brazilian biodiversity and uses only vegetable raw material derived from environmental renewable resources, promoting and investing in the new bioactive prospecting to enhance its range of selected products.
The biotechnological process of Phytoplenus consists, briefly, of the isolation of molecular components extracted from a living organism, or from a medicinal plant. These components are biomolecules that have therapeutical activity and can be used to repair skin lesions in humans.
The purpose of Phytoplenus’ bioactive compounds isolation process is to remove the substances and/or bioactive compounds present in the herbal drug the most selective and complete way by using combinations of molecular complexes which selectively encapsulate and solvate the bioactive compound of interest. This process separates quantitatively and qualitatively the components of interest, in a quick, simple and low-cost way.
Phytoplenus’ technology has numerous advantages over the conventional methods of extraction, most of which frequently lose bioactive compounds due to oxidation processes – mainly caused by high temperatures and oxygen.
The process of isolating the bioactive compounds from the vegetable raw material used by Phytoplenus is largely controlled, which prevents oxidation and degradation reactions, and results in preparations of high biochemical diversity, which is important for molecular synergism and for therapeutic action.
The quality of Phytoplenus’ products is guaranteed by a Quality Control Laboratory equipped with the most advanced analytical technologies that perform physical-chemical and chromatographical analysis.
The composition and the content of the therapeutically important bioactive compounds of the raw materials and plant extracts produced by Phytoplenus are carefully analyzed. Chromatographical techniques such as Thin Layer Chromatography (TLC) and High Performance Liquid Chromatography (HPLC) are used to identify and quantify the relevant bioactive compounds.
All quality control documentation, including analysis certificates issued by the Quality Control Laboratory, are in accordance with the current sanitary legislation and the Good Manufacturing Practices (GMP), ensuring good quality and traceability of Phytoplenus’ products.